Annual Report 2024–25

Ovarian Cancer Action has been at the heart of global ovarian cancer research for 40 years. Their 2024/25 annual report highlights major strides including the development of the world's first ovarian cancer vaccine, the launch of a new Global Research Consortium, and a high-profile Coronation Street partnership to raise symptom awareness. Their goal is for 50% of women to survive more than 10 years after diagnosis by 2032.

Report snapshot
40 Views

📋About

Ovarian Cancer Action Research Centre; Helene Harris Memorial Trust (HHMT) International Forum; Global Ovarian Cancer Research Consortium ($1m AI grant); Patient Research Network; OvarianVax vaccine development (University of Oxford); symptom awareness campaigns; Coronation Street partnership; BRCA community outreach Custom geography from upload: UK

📊Key Metrics

264,000 people accessed the OCA website in 2024/25 Key Metric 1
Nearly 200,000 people reached through Ovarian Cancer Awareness Month campaign Key Metric 2
Over 10,000 people completed the genetic risk tool Key Metric 3

Key Outcomes

  • World-first ovarian cancer vaccine (OvarianVax) development unlocked, with Cancer Research UK funding secured; potential to move to human clinical trials within five years
  • Global Ovarian Cancer Research Consortium established with leading charities in USA, Australia and Canada, including a $1 million AI research grant
  • Coronation Street partnership drove over 100,000 visits to symptom pages and reached millions through digital campaigns and major media coverage

📍Geography

Other

2026 Enhanced

Impact — Winter 2026

Total income £18,180,000 and total expenditure £18,560,000 (year ended 31 December 2024, charity no. 1084958 England/Wales and SC039654 Scotland); in 2024 spent £3.8m on charitable activities including £1,079,000 on research, £1,366,000 on EB Community Support, £943,000 on public education, £270,000 on EB healthcare and £185,000 on respite breaks
Key Metric 1
700+ members supported through in-person visits and support calls in 2025; 697 support grants allocated in 2025 for essential items including specialist clothing, cooling fans and sheepskin liners; 2 new holiday homes purchased in 2025 with over 700 guests enjoying holiday homes; £34,000 raised through 2025 winter 'The Longest Night' appeal
Key Metric 2
Largest global investment in EB research to date: multi-million-pound drug repurposing trial provisionally agreed with LifeArc partner at Guy's and St Thomas' NHS Foundation Trust and King's College London; EB Priorities Setting Partnership study completed mapping global research priorities for all four main EB forms
Key Metric 3
£34,000 raised in 2025 winter appeal supporting families like Darcie's with specialist items, emotional support and research; 697 support grants delivered in 2025; first Members Connect event in Northern Ireland; EB Priorities Setting Partnership study completed providing global research roadmap
2025 Enhanced

Impact Report 2025

22,507 households helped through RBL casework and specialist support services across 66 countries
Key Metric 1
22,600 grants given to those in need, totalling £11.8 million
Key Metric 2
733 beneficiaries represented at tribunals, resulting in £24.5 million in War Pensions awards
Key Metric 3
1,548 new families living with dementia supported by RBL Admiral Nurses service
2025 Enhanced

Our Impact 2024-25

3,600 blind veterans received support across the UK; 447 new blind veterans started receiving support in 2024/25
Key Metric 1
1,598 referrals to rehabilitation services completed; 313 veterans received assistive technology training
Key Metric 2
997 volunteers donated 26,824 hours of support; befriending service awarded Quality in Befriending Excellence — one of only 11 organisations in the UK to achieve this
Key Metric 3
1,831 National Creative Wellbeing Project packs issued to help veterans reconnect with creativity and independence